Published in Epidemiol Infect on December 01, 1987
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev (1996) 13.25
Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol (1997) 2.45
Species, biotype, and bacteriophage type determinations compared with cell envelope protein profiles for typing Acinetobacter strains. J Clin Microbiol (1990) 2.32
Use of protein profiles to identify Acinetobacter calcoaceticus in a respiratory care unit. J Clin Pathol (1989) 1.04
Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center. J Clin Microbiol (2010) 0.93
Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization. Antimicrob Agents Chemother (2012) 0.85
Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns. Adv Biomed Res (2015) 0.81
Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii. Res Pharm Sci (2017) 0.75
Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands. FEBS Lett (1975) 26.78
Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68
Moraxella, Acinetobacter, and the Mimeae. Bacteriol Rev (1973) 3.43
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Cell envelope protein profiles of Acinetobacter calcoaceticus strains isolated in hospitals. J Med Microbiol (1987) 2.78
Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J Infect Dis (1984) 2.28
Hospital outbreak of multi-resistant Acinetobacter anitratus: an airborne mode of spread? J Hosp Infect (1987) 2.17
Fingerprinting Acinetobacter strains from clinical sources by numerical analysis of electrophoretic protein patterns. J Med Microbiol (1984) 1.92
Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae. J Infect Dis (1986) 1.90
Acinetobacter bacteriocin typing. J Hosp Infect (1986) 1.61
A report of a further hospital outbreak caused by a multi-resistant Acinetobacter anitratus. J Hosp Infect (1982) 1.20
Serotyping of Acinetobacter calcoaceticus. J Clin Pathol (1984) 1.02
[Bioenzymatic and lysotypic study of 200 strains of Acinetobacter calcoaceticus]. Pathol Biol (Paris) (1984) 0.83
Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet (1992) 3.58
Cell envelope protein profiles of Acinetobacter calcoaceticus strains isolated in hospitals. J Med Microbiol (1987) 2.78
Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med (1992) 2.67
Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol (2000) 2.53
Evaluation of an enzyme immunoassay for the diagnosis of chlamydial infections in urogenital specimens. J Clin Microbiol (1986) 2.44
Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam. Br J Vener Dis (1974) 2.31
Rapid identification of bacteria in blood cultures by using fluorescently labeled oligonucleotide probes. J Clin Microbiol (2000) 2.29
Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol (1991) 2.21
Detection of Neisseria gonorrhoeae antigen by a solid-phase enzyme immunoassay. Br J Vener Dis (1982) 1.94
Transgenic poplars: expression of chimeric genes using four different constructs. Plant Cell Rep (1992) 1.91
Rising incidence of chancroid in Rotterdam. Epidemiological, clinical, diagnostic, and therapeutic aspects. Br J Vener Dis (1979) 1.87
[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia]. Ned Tijdschr Geneeskd (2005) 1.85
Activity of eight antimicrobial agents in vitro against N. Gonorrhoeae. Br J Vener Dis (1975) 1.84
Factors influencing detection of tolerance in Staphylococcus aureus. Antimicrob Agents Chemother (1982) 1.77
Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol (1996) 1.72
Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. Antimicrob Agents Chemother (1986) 1.64
Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J Infect Dis (1985) 1.63
Antibiotic sensitivities of gonococci isolated in Rotterdam and results of treatment with cefuroxime. Br J Vener Dis (1980) 1.60
Survival of Chlamydia trachomatis in different transport media and at different temperatures: diagnostic implications. Br J Vener Dis (1984) 1.59
Comparison of HeLa 229 and McCoy cell cultures for detection of Chlamydia trachomatis in clinical specimens. J Clin Microbiol (1989) 1.56
Gonorrhea in Rotterdam caused by penicillinase-producing gonococci. Br J Vener Dis (1980) 1.55
Comparison of two matrix-assisted laser desorption ionisation-time of flight mass spectrometry methods for the identification of clinically relevant anaerobic bacteria. Clin Microbiol Infect (2011) 1.51
Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males. Antimicrob Agents Chemother (1987) 1.47
Evaluation of the effects of storage in two different swab fabrics and under three different transport conditions on recovery of aerobic and anaerobic bacteria. J Clin Microbiol (1999) 1.42
The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol (2001) 1.40
Paradoxical dose effect of continuously administered cloxacillin in treatment of tolerant Staphylococcus aureus endocarditis in rats. J Antimicrob Chemother (1994) 1.39
Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. J Infect Dis (1985) 1.39
Septic melioidosis after a visit to Southeast Asia. Eur J Clin Microbiol (1986) 1.38
Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin. Antimicrob Agents Chemother (1994) 1.38
Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob Agents Chemother (1990) 1.37
[Management of the resistance problem by using an antibiotic protocol]. Ned Tijdschr Geneeskd (1992) 1.37
Evaluation of the direct fluorescent antibody test for diagnosis of chlamydial infections. Eur J Clin Microbiol (1985) 1.35
Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis. Arch Intern Med (1992) 1.33
Penicillinase-producing strains of Neisseria gonorrhoeae isolated in Rotterdam. Br J Vener Dis (1977) 1.30
Identification of Gram-positive anaerobic cocci by MALDI-TOF mass spectrometry. Syst Appl Microbiol (2011) 1.30
Resistance of Neisseria gonorrhoeae to enoxacin. J Antimicrob Chemother (1986) 1.30
The identification of anaerobic bacteria using MALDI-TOF MS. Anaerobe (2011) 1.28
Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in The Netherlands. Eur J Clin Microbiol Infect Dis (1991) 1.27
Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats. Eur J Clin Microbiol (1984) 1.27
Faecal carriage of aerobic gram-negative bacilli and drug resistance of Escherichia coli in different age-groups in Dutch urban communities. J Med Microbiol (1983) 1.22
Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g. J Antimicrob Chemother (1984) 1.22
A solid medium for visual demonstration of coagulase production by Staphylococcus aureus. J Clin Pathol (1972) 1.19
Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis. Infect Immun (1979) 1.19
Quantitative study of the aerobic and anaerobic faecal flora in neonatal necrotising enterocolitis. Arch Dis Child (1983) 1.18
Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS). Clin Microbiol Infect (2000) 1.17
Comparison of clinical Acinetobacter strains using a carbon source growth assay. Epidemiol Infect (1990) 1.17
Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin. Eur J Clin Microbiol (1986) 1.16
Antibiotic resistance: era of the multidrug pump. Mol Microbiol (2000) 1.15
Endemic acinetobacter in intensive care units: epidemiology and clinical impact. J Clin Pathol (1993) 1.15
Immunochemical studies on the group and type antigens of group F streptococci and the identification of a grouplike carbohydrate in a type II strain with an undesignated group antigen. J Exp Med (1967) 1.14
Mastitis and toxic shock syndrome (tampon disease). Neth J Surg (1985) 1.14
SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med (2012) 1.14
Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats. Antimicrob Agents Chemother (1985) 1.13
Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci. J Antimicrob Chemother (1990) 1.13
Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats. Antimicrob Agents Chemother (1982) 1.12
Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer (1989) 1.11
Infections with non-penicillinase-producing Neisseria gonorrhoeae treated with cefuroxime: treatment failures. Sex Transm Dis (1987) 1.08
Distinguishing complicated from uncomplicated bacteremia caused by Staphylococcus aureus: the value of "new" and "old" serological tests. J Infect Dis (1986) 1.07
Population Heterogeneity of Agrobacterium tumefaciens in Galls of Populus L. from a Single Nursery. Appl Environ Microbiol (1987) 1.06
Solid-phase enzyme immunoassay for detection of Chlamydia trachomatis. Eur J Clin Microbiol (1985) 1.06
A study of virulence factors with induced mutants of Staphylococcus aureus. J Med Microbiol (1975) 1.06
Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages. Antimicrob Agents Chemother (1986) 1.06
Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. Antimicrob Agents Chemother (1987) 1.05
Use of protein profiles to identify Acinetobacter calcoaceticus in a respiratory care unit. J Clin Pathol (1989) 1.04
Ampicillin susceptibility and ampicillin-induced killing rate of Escherichia coli. Antimicrob Agents Chemother (1982) 1.04
Treatment of lymphogranuloma venereum with rifampicin. Br J Vener Dis (1979) 1.03
Gonococcal serology. A comparison of three different tests. Br J Vener Dis (1983) 1.03
Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens. Clin Microbiol Infect (2007) 1.03
Demonstration of antigenic heterogeneity of Neisseria gonorrhoeae pili antigens using human sera in the test system. Acta Pathol Microbiol Immunol Scand C (1982) 1.03
Immunochemistry of the carbohydrate antigens of some Streptococcus salivarius strains. J Gen Microbiol (1971) 1.02
Nosocomial klebsiellas. I. Colonization of hospitalized patients. J Hyg (Lond) (1979) 1.01
16S ribosomal RNA-targeted oligonucleotide probes for monitoring of intestinal tract bacteria. Scand J Gastroenterol Suppl (1997) 1.01
Antibodies against Chlamydia of lymphogranuloma-venereum type in Crohn's disease. Lancet (1979) 1.01
Sensitivity of gonococcus strains isolated in Rotterdam to epicillin, ampicillin, penicillin and tetracycline. Dermatologica (1978) 1.00
Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin). Genitourin Med (1986) 0.99
Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains. Antimicrob Agents Chemother (1984) 0.99
Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J Hosp Infect (1999) 0.99
In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis. Eur J Clin Microbiol (1986) 0.99
Denaturing gradient gel electrophoresis analysis to study bacterial community structure in pockets of periodontitis patients. Oral Microbiol Immunol (2003) 0.98
Pericarditis, pneumonia and brain abscess due to a combined Actinomyces--Actinobacillus actinomycetemcomitans infection. J Infect (1992) 0.98
Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells. J Clin Microbiol (1992) 0.97
Sexually communicable micro-organisms in human semen samples to be used for artificial insemination by donor. Genitourin Med (1987) 0.97
Evaluation of the Vitek 2 ANC card for identification of clinical isolates of anaerobic bacteria. J Clin Microbiol (2011) 0.97
In vitro development and stability of tolerance to cloxacillin and vancomycin in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1994) 0.97
Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols. Appl Environ Microbiol (1993) 0.96
Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusion. J Antimicrob Chemother (1991) 0.96
The effects of medium and rate of freezing on the survival of chlamydias after lyophilization. J Appl Bacteriol (1993) 0.95
Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin. Eur J Clin Microbiol (1986) 0.95
Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int J Cancer (1985) 0.94
Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis. J Med Microbiol (1990) 0.94
Prevalence of antibodies to Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in infertile women. Genitourin Med (1985) 0.93
Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice. Antimicrob Agents Chemother (1984) 0.93
Amiodarone-induced enhancement of doxorubicin and 4'-deoxydoxorubicin cytotoxicity to rat colon cancer cells in vitro and in vivo. Cancer Res (1986) 0.93
Endoscope disinfection and its pitfalls--requirement for retrograde surveillance cultures. Endoscopy (2008) 0.92
Antimicrobial susceptibility of clinically relevant Gram-positive anaerobic cocci collected over a three-year period in the Netherlands. Antimicrob Agents Chemother (2010) 0.92